Sponsored by
US go-ahead for Glaxo flu vaccine
US health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline, the company said.
The US Food and Drug Administration has approved Fluarix Quadrivalent to immunise children aged three and older and adults against flu virus subtypes A and B contained in the vaccine.
It is the first intramuscular vaccine to protect against four influenza strains. Three-strain flu vaccines currently administered help protect against the two most common A virus strains and the B strain expected to be predominant in a given year, the company said.
Since 2000, however, two B virus strains have circulated to varying degrees each season, meaning patients infected with the B virus not contained in the vaccine were not immunised.
Email to a friend
Print this page- Books confirm Gulf owners seeking new investment in Leeds Utd
- Gulf owner sells off more of Leeds Utd - but not to Ken Bates
- Huge queues as crash shuts M62 between Leeds and Bradford
- ‘Value play’ as Gulf bank’s books reveal more gambling over Leeds future
- Bolton’s Matt Mills could be £1m Leeds transfer target
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Yorkshire
Sunday 19 May 2013
Today
Sunny spells
Temperature: 9 C to 18 C
Wind Speed: 13 mph
Wind direction: North west
Tomorrow
Cloudy
Temperature: 10 C to 16 C
Wind Speed: 17 mph
Wind direction: North
